Data di Pubblicazione:
2022
Citazione:
Heart failure with normal LVEF in BIOSTAT-CHF / Baumhove, Lukas; Tromp, Jasper; Figarska, Sylwia; Van Essen, Bart J; Anker, Stefan D; Dickstein, Kenneth; Cleland, John G; Lang, Chim C; Filippatos, Gerasimos; Ng, Leong L; Samani, Nilesh J; Metra, Marco; Van Veldhuisen, Dirk J; Lam, Carolyn S P; Voors, Adriaan A; Van Der Meer, Peter. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 364:(2022), pp. 85-90. [10.1016/j.ijcard.2022.05.054]
Abstract:
Several studies have shown that heart failure (HF) drug treatment seems to benefit patients with preserved ejection fraction (HFpEF) and a left ventricular ejection fraction (LVEF) up to 55-60% but not with higher LVEF. Certain HF drugs are now indicated in patients with HFpEF and a LVEF below normal. However, not much is known about patients with a normal LVEF. Therefore, we investigated the prevalence, clinical characteristics and outcome of patients with HF and a normal LVEF.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
BIOSTAT-CHF; Heart failure; LVEF; Normal LVEF; Women
Elenco autori:
Baumhove, Lukas; Tromp, Jasper; Figarska, Sylwia; Van Essen, Bart J; Anker, Stefan D; Dickstein, Kenneth; Cleland, John G; Lang, Chim C; Filippatos, Gerasimos; Ng, Leong L; Samani, Nilesh J; Metra, Marco; Van Veldhuisen, Dirk J; Lam, Carolyn S P; Voors, Adriaan A; Van Der Meer, Peter
Link alla scheda completa:
Pubblicato in: